Search Results 41 – 60 of 3231
Cabotegravir / Rilpivirine
https://clinicalinfo.hiv.gov/drugs/cabotegravir-rilpivirine/patient
Cabotegravir / Rilpivirina
https://clinicalinfo.hiv.gov/drugs/cabotegravir-rilpivirine/patient
Cabotegravir / Rilpivirine
https://clinicalinfo.hiv.gov/drugs/cabotegravir-rilpivirine/fda-label
Fostemsavir
https://clinicalinfo.hiv.gov/guidelines/pediatric-arv/fostemsavir
Cabotegravir
https://clinicalinfo.hiv.gov/guidelines/pediatric-arv/cabotegravir
Tenofovir Alafenamide
https://clinicalinfo.hiv.gov/drugs/tenofovir-alafenamide/patient
Alafenamida de tenofovir
https://clinicalinfo.hiv.gov/drugs/tenofovir-alafenamide/patient
Tenofovir Alafenamide
https://clinicalinfo.hiv.gov/drugs/tenofovir-alafenamide/fda-label
What to Start: Initial Combination Antiretroviral Regimens
https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/what-start-initial-combination-regimens
What to Start: Protease Inhibitor–Based Regimens
https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/what-start-protease-inhibitor-based-regimens
What to Start: Advantages and Disadvantages of Antiretroviral Components of Initial Antiretroviral Therapy
https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/what-start-advantages-disadvantages
What to Start: Other Antiretroviral Regimens When Abacavir and Tenofovir Cannot Be Used or Are Not Optimal
https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/what-start-other-antiretroviral-regimens
What to Start: Initial Antiretroviral Therapy Based on Specific Clinical Scenarios
https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/what-start-initial-antiretroviral-specific-clinical-scenarios
What to Start: Non-Nucleoside Reverse Transcriptase Inhibitor Regimens
https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/what-start-non-nucleoside-reverse-transcriptase-inhibitor
What to Start: Integrase Strand Transfer Inhibitor Regimens
https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/what-start-integrase-strand-transfer-inhibitor
What to Start: Nucleoside Reverse Transcriptase Inhibitor Options
https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/what-start-nucleoside-reverse-transcriptase-inhibitor
Drug-Drug Interactions: HIV-1 gp120 Inhibitors and Other Drugs
https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/drug-interactions-hiv-1-gp120-inhibitors
All Archived Guidelines
https://clinicalinfo.hiv.gov/guidelines/archived-guidelines/all-archived-guidelines
Adult and Adolescent ARV Archive
https://clinicalinfo.hiv.gov/guidelines/archived-guidelines/adult-and-adolescent-guidelines
Adult and Adolescent Opportunistic Infection Archive
https://clinicalinfo.hiv.gov/guidelines/archived-guidelines/adult-oi-guidelines